Strong annexin A2 immunostaining was observed in 90% (38/42) of the serous ovarian cancer cells and was significantly increased in the cancer-associated stroma compared to non-malignant ovarian tissues. This evidence concerns the gene ANXA2 and ovarian serous adenocarcinoma.